由总状共头霉感染引起的腹腔内接合菌病经部分手术清创和高剂量两性霉素B脂质体复合物成功治愈。
Intraabdominal zygomycosis caused by Syncephalastrum racemosum infection successfully treated with partial surgical debridement and high-dose amphotericin B lipid complex.
作者信息
Schlebusch Sanmarié, Looke David F M
机构信息
Division of Microbiology, Princess Alexandra Hospital, Ipswich Road, Woolloongabba, Brisbane Qld 4102, Australia.
出版信息
J Clin Microbiol. 2005 Nov;43(11):5825-7. doi: 10.1128/JCM.43.11.5825-5827.2005.
Abstract
Invasive zygomycosis rarely complicates trauma. We describe the first recorded case of invasive infection of the anterior abdominal wall and omentum with the zygomycete Syncephalastrum racemosum, which was successfully treated with partial surgical debridement and amphotericin B lipid complex.
摘要
侵袭性接合菌病很少并发于创伤。我们描述了首例有记录的由总状共头霉这种接合菌引起的前腹壁和网膜侵袭性感染病例，该病例通过部分手术清创和两性霉素B脂质体复合物成功治愈。
相似文献
1
Intraabdominal zygomycosis caused by Syncephalastrum racemosum infection successfully treated with partial surgical debridement and high-dose amphotericin B lipid complex.
J Clin Microbiol. 2005 Nov;43(11):5825-7. doi: 10.1128/JCM.43.11.5825-5827.2005.
2
Abdominal wall mucormycosis successfully treated with amphotericin and itraconazole.
J Infect. 2002 Apr;44(3):203-4. doi: 10.1053/jinf.2002.0972.
3
Invasive cutaneous mucormycosis caused by Absidia corymbifera after allogeneic bone marrow transplantation.
Bone Marrow Transplant. 1996 Jul;18(1):229-30.
4
Palate ulcer due to mucormycosis.
J Laryngol Otol. 2002 Feb;116(2):146-7. doi: 10.1258/0022215021909917.
5
Favorable outcome of amphotericin B treatment of zygomycotic necrotizing fascitis caused by Apophysomyces elegans.
Int J Dermatol. 2008 Apr;47(4):407-9. doi: 10.1111/j.1365-4632.2008.03622.x.
6
Outcomes of invasive zygomycosis infections in renal transplant recipients.
Transpl Infect Dis. 2007 Jun;9(2):161-4. doi: 10.1111/j.1399-3062.2006.00197.x.
7
Lipid-based amphotericin in pulmonary zygomycosis: safety and efficacy of high exposure in a renal allograft recipient.
Transpl Infect Dis. 2004 Dec;6(4):183-7. doi: 10.1111/j.1399-3062.2004.00076.x.
8
Combination therapy with amphotericin B lipid complex and caspofungin acetate of disseminated zygomycosis in diabetic ketoacidotic mice.
Antimicrob Agents Chemother. 2005 Feb;49(2):830-2. doi: 10.1128/AAC.49.2.830-832.2005.
9
Successful non-surgical treatment of disseminated polymicrobial fungal infection in a patient with pancytopenia and graft-versus-host disease.
J Infect. 2000 Nov;41(3):273-5. doi: 10.1053/jinf.2000.0739.
10
引用本文的文献
1
High-dose amphotericin: yay or nay? A case series and literature review.
Drugs Context. 2024 Jan 15;13. doi: 10.7573/dic.2023-9-1. eCollection 2024.
2
sp. nov. and sp. nov. Isolated from Clinical Samples.
J Fungi (Basel). 2024 Jan 13;10(1):64. doi: 10.3390/jof10010064.
3
COVID-19 associated mucormycosis: evolving technologies for early and rapid diagnosis.
3 Biotech. 2022 Jan;12(1):6. doi: 10.1007/s13205-021-03080-4. Epub 2021 Dec 6.
4
Invasive pulmonary infection by species: Two case reports and review of literature.
IDCases. 2020 Jul 25;21:e00913. doi: 10.1016/j.idcr.2020.e00913. eCollection 2020.
5
Gastrointestinal involvement of unusual Mucormycete Syncephalastrum racemosum in a diabetic patient with adenocarcinoma: rare case presentation with review of literature.
Infection. 2020 Oct;48(5):791-797. doi: 10.1007/s15010-020-01455-y. Epub 2020 Jun 6.
6
Updates on the Taxonomy of Mucorales with an Emphasis on Clinically Important Taxa.
J Fungi (Basel). 2019 Nov 14;5(4):106. doi: 10.3390/jof5040106.
7
Onychomycosis by syncephalastrum racemosum: case report from kerala, India.
Dermatol Reports. 2015 Mar 30;7(1):5527. doi: 10.4081/dr.2017.5527. eCollection 2015 Mar 16.
8
Mucormycosis in a Non-Hodgkin Lymphoma Patient Caused by Syncephalastrum racemosum: Case Report and Review of Literature.
Mycopathologia. 2015 Aug;180(1-2):89-93. doi: 10.1007/s11046-015-9878-1. Epub 2015 Mar 5.
9
Mucormycosis caused by unusual mucormycetes, non-Rhizopus, -Mucor, and -Lichtheimia species.
Clin Microbiol Rev. 2011 Apr;24(2):411-45. doi: 10.1128/CMR.00056-10.
10
[Invasive mycoses and trauma].
Wien Med Wochenschr. 2007;157(19-20):482-9. doi: 10.1007/s10354-007-0463-1.
本文引用的文献
1
Zygomycosis.
Infect Dis Clin North Am. 2002 Dec;16(4):895-914, vi. doi: 10.1016/s0891-5520(02)00037-5.
2
Infection in penetrating abdominal trauma: risk factors and preventive antibiotics.
Am Surg. 2002 Jan;68(1):29-35.
3
Zygomycetes in human disease.
Clin Microbiol Rev. 2000 Apr;13(2):236-301. doi: 10.1128/CMR.13.2.236.
4
In vitro susceptibility to 9 antifungal agents of 14 strains of Zygomycetes isolated from clinical specimens.
Mycopathologia. 1994 Dec;128(3):135-7. doi: 10.1007/BF01138473.
5
Cutaneous infection by Syncephalastrum.
Sabouraudia. 1980 Mar;18(1):19-20.
6
Experimental cerebral zygomycosis in alloxan-diabetic rabbits: variation in virulence among zygomycetes.
Sabouraudia. 1981 Dec;19(4):245-56. doi: 10.1080/00362178185380421.
7
Saprophytic molds as agents of cutaneous and subcutaneous infection in the immunocompromised host.
Arch Dermatol. 1986 Oct;122(10):1161-8.
8
Wound zygomycosis (mucormycosis) in otherwise healthy adults.
Am J Med. 1988 Mar;84(3 Pt 1):546-8. doi: 10.1016/0002-9343(88)90282-3.
9
An intracavitary fungus ball composed of syncephalastrum.
Am Rev Respir Dis. 1979 Oct;120(4):943-7. doi: 10.1164/arrd.1979.120.4.943.
Zotero 插件